慢性乙型肝炎患者的估计球过率的纵向变化 治疗Tenofovir Alafenamide与Entecavir
Xuan Li1,2, Qiang Wu3, Fang Huang4
1Department of Liver Diseases, Shenzhen Third People's Hospital, Shenzhen, Guangdong, China.
PeerJ
|September 2, 2025
概括
在慢性乙型肝炎 (CHB) 治疗中推使用特诺福维尔阿拉芬胺 (TAF) 和恩特卡维尔 (ETV). 这项研究发现TAF在安全性方面与ETV相当,TAF对男性和老年患者有好处.
科学领域:
- 肝病学
- 肝脏病学
- 药理学
背景情况:
- 慢性乙型肝炎 (CHB) 的治疗包括抗病毒疗法,具有不同的毒性风险.
- 对于具有较高损伤风险的CHB患者,推使用恩特卡维尔 (ETV) 和特诺福维尔阿拉芬胺 (TAF).
- 在未接受过治疗的CHB患者中,研究TAF与ETV对的比较安全性至关重要.
研究的目的:
- 在以前未接受治疗的慢性乙型肝炎 (CHB) 患者中比较特诺福维尔阿拉芬胺 (TAF) 和恩特卡维尔 (ETV) 的安全性.
- 在两种抗病毒治疗之间分析慢性病 (CKD) 的发生率和估计球过率 (eGFR) 的变化.
- 确定可能从TAF或ETV中获得更大的脏健康益处的患者子组.
主要方法:
- 一项队列研究包括在2019年7月至2020年12月期间接受TAF或ETV的466名以前未接受治疗的CHB患者.
- 监测了估计的膜过率 (eGFR),并通过考克斯回归分析确定了与慢性病发展相关的因素.
- 一般化添加剂混合模型 (GAMM) 评估了时间 eGFR 变化和抗病毒药物的影响.
主要成果:
- 在基线eGFR> 90mL/ min/ 1. 73m2的患者中,TAF和ETV组的整体CKD发病率是可比的 (9. 8%与13. 9%,p=0. 304).
- 男性的性别和较低的基线EGFR是CKD发展的显著预测因素.
- 与ETV相比,TAF与显著较低的eGFR下降率相关 (调整后的差异:0. 38mL/ min/ 1. 73m2/ 12周,p=0. 006),特别是在男性和35岁以上的患者中.
结论:
- 在未接受过治疗的CHB患者中,丁胺 (TAF) 的安全性与恩特卡维尔 (ETV) 相当.
- 在特定的亚组中,TAF对脏的益处高于ETV,包括男性和35岁以上的患者.
- 这些发现支持个性化抗病毒选择用于CHB管理以优化脏保护.
相关概念视频
Renal Drug Excretion: Glomerular Filtration
497
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production occurs. A nephron has two main components: a renal corpuscle and a renal tubule.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
497
Renal Failure: Dose Adjustments
152
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
152
Hepatic Drug Excretion: Influencing Factors
214
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
214
Glomerular Filtration Rate and its Regulation
3.3K
The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
3.3K
Drug Elimination by Renal Route: Glomerular Filtration
5.9K
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production takes place. A nephron has two main components: a renal corpuscle and a renal tubule. Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent...
5.9K
Hepatic Drug Excretion: Enterohepatic Cycling
1.7K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.7K


